PharmX Technologies (ASX:PHX) confirmed the renewal of its existing exclusive agreement with the National Diabetes Services Scheme (NDSS), with a 24-month extension to the existing arrangement starting July 1, according to a Tuesday Australian bourse filing.
NDSS ordering continues to be one of the most frequent and operationally embedded digital workflows in Australian pharmacies, the filing noted.